CFTR Modulator Adherence High in Kids, Teens on Symdeko, Orkambi

CFTR Modulator Adherence High in Kids, Teens on Symdeko, Orkambi

296433

CFTR Modulator Adherence High in Kids, Teens on Symdeko, Orkambi

Children and adolescents on Symdeko (tezacaftor/ivacaftor) and Orkambi (ivacaftor/lumacaftor) for cystic fibrosis (CF) had higher treatment adherence rates compared with adults given the same CFTR modulators, a nationwide study in the U.S. found. The study also showed that adherence — patients choosing to follow through with a prescribed treatment — among people of all ages with CF was higher for those taking Symdeko than other CFTR modulators. Such therapies target defects in the CFTR protein that is…

You must be logged in to read/download the full post.